Contact us to get started
However, achieving weight loss solely by dietary and/or exercise interventions is very challenging for most individuals living with obesity [14]
While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy
Check out the OOP Talent Collective - where vetted candidates are looking for their next gig
In the mesolimbic system, neurons (such as those in the nucleus of the solitary tract) projecting to the VTA and NAc are the most likely source of endogenous GLP-1
Melanotan 2s receptor-specific activity makes it ideal for laboratory investigations into pigmentation disorders, melanocyte function, and peptide pharmacodynamics